Cite
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
MLA
Imai, Masaki, et al. “Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.” The New England Journal of Medicine, vol. 388, no. 1, Jan. 2023, pp. 89–91. EBSCOhost, https://doi.org/10.1056/NEJMc2214302.
APA
Imai, M., Ito, M., Kiso, M., Yamayoshi, S., Uraki, R., Fukushi, S., Watanabe, S., Suzuki, T., Maeda, K., Sakai-Tagawa, Y., Iwatsuki-Horimoto, K., Halfmann, P. J., & Kawaoka, Y. (2023). Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB. The New England Journal of Medicine, 388(1), 89–91. https://doi.org/10.1056/NEJMc2214302
Chicago
Imai, Masaki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Ryuta Uraki, Shuetsu Fukushi, Shinji Watanabe, et al. 2023. “Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.” The New England Journal of Medicine 388 (1): 89–91. doi:10.1056/NEJMc2214302.